Not available?

Another study finds no benefit from cognitive behavioral therapy and contingency management with opiate replacement treatment. [CORRECTED: See below] Background and aims The Controlled Substances Act requires physicians in the United States to provide or refer to behavioral treatment when treating opioid-dependent individuals with buprenorphine; however no research has examined the combination of buprenorphine with … Continue reading Not available?

Twelve-Step attendance trajectories over 7 years among adolescents

More evidence for the benefits of 12 step facilitation for adolescents: Results of multivariate logistic GEE models indicated that adolescents with continued 12-Step attendance had better outcomes over time, whereas those in the early but not continued group had no different long-term outcomes compared to those in the low/no attendance group. A problem, of course, … Continue reading Twelve-Step attendance trajectories over 7 years among adolescents

Treating depression and substance use: no significant difference from control

Another study finds treatment as usual to be just as effective as specialized CBT: Few integrated substance use and depression treatments have been developed for delivery in outpatient substance abuse treatment settings. To meet the call for more “transportable” interventions, we conducted a pilot study to test a group cognitive–behavioral therapy (CBT) for depression and … Continue reading Treating depression and substance use: no significant difference from control

Ritalin Gone Wrong

Not surprisingly, we get a lot of clients who have been diagnosed with ADD or ADHD. Many are concerned about suggestions to discontinue prescription stimulants. This NYT opinion piece has gotten a lot of buzz over the last couple of days: In 30 years there has been a twentyfold increase in the consumption of drugs for attention-deficit … Continue reading Ritalin Gone Wrong